Therapeutic drug monitoring-guided dosing of busulfan differs from weight-based dosing in hematopoietic stem cell transplant patients-Reference-Cited by-同舟云学术

Therapeutic drug monitoring-guided dosing of busulfan differs from weight-based dosing in hematopoietic stem cell transplant patients

Published:2017-06 Issue:2 Volume:10 Page:70-78
ISSN:1658-3876
Container-title:Hematology/Oncology and Stem Cell Therapy
language:en
Short-container-title:Hematology/Oncology and Stem Cell Therapy

Author:

Salman Bushra,Al-Za'abi Mohammed,Al-Huneini Mohammed,Dennison David,Al-Rawas Abdulhakeem,Al-Kindi Salam,Al-Farsi Khalil,Tauro Melanie,Al-Khabori Murtadha

Publisher

Elsevier BV

Subject

Oncology,Hematology,General Medicine

Reference30 articles.

1. Personalized busulfan and treosulfan conditioning for pediatric stem cell transplantation: the role of pharmacogenetics and pharmacokinetics;ten Brink;Drug Discov Today,2014

2. Busulfan in hematopoietic stem cell transplantation;Ciurea;Biol Blood Marrow Transplant,2009

3. Randomized comparison of four-times-daily versus once-daily intravenous busulfan in conditioning therapy for hematopoietic cell transplantation;Ryu;Biolg Blood Marrow Transplant,2007

4. Development of a rapid and specific assay for detection of busulfan in human plasma by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry;dos Reis;Rapid Commun Mass Spectrom,2005

5. Basic pharmacokinetics;Jambhekar,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simulation-Based Optimization of Sampling Schedules for Model-Informed Precision Dosing of Once-Daily and 4-Times-Daily Busulfan in Pediatric Patients;Therapeutic Drug Monitoring;2024-06-14

2. Management of transfusion-dependent β-thalassemia (TDT): Expert insights and practical overview from the Middle East;Blood Reviews;2024-01

3. Clinical Relevance of Therapeutic Drug Monitoring of Busulfan-Based Regimens in Adult Hematopoietic Stem Cell Transplant Patients;Archives of Pharmacy Practice;2024

4. Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT;Transplantation and Cellular Therapy;2023-12

5. Limited Sampling Strategy Using End of Infusion and Six-Hour Concentrations Overestimates Intravenous Busulfan Clearance Compared With Standard Six-Point Sampling in Hematopoietic Stem Cell Transplant Patients;Therapeutic Drug Monitoring;2023-07-13